Proteasome-mediated degradation of intracellular proteins is essential for cell function and survival. The proteasome-binding protein PI31 (Proteasomal Inhibitor of 31kD) promotes 26S assembly and functions as an adapter for proteasome transport in axons. As localized protein synthesis and degradation is especially critical in neurons, we generated a conditional loss of PI31 in spinal motor neurons (MNs) and cerebellar Purkinje cells (PCs). A cKO of PI31 in these neurons caused axon degeneration, neuronal loss and progressive spinal and cerebellar neurological dysfunction. For both MNs and PCs, markers of proteotoxic stress preceded axonal degeneration and motor dysfunction, indicating a critical role for PI31 in neuronal homeostasis. The time course of the loss of MN and PC function in developing mouse CNS suggests a key role for PI31 in human developmental neurological disorders.
Introduction
The regulated breakdown of proteins is essential for cell function and survival.
The Ubiquitin-Proteasome System (UPS) is responsible for the degradation of soluble intracellular proteins, whereas autophagy primarily serves to remove protein aggregates and damaged organelles (1) (2) (3) (4) (5) (6) (7) (8) . UPS-mediated protein degradation involves two major steps: first, a protein is tagged with a chain of ubiquitin molecules, and then poly-ubiquitinated substrates are cleaved into small peptides by the 26S proteasome (2, 9, 10) . Although protein homeostasis is thought to be a critical feature of neuronal circuit function, the major emphasis has been the importance of local protein translation (11, 12) . It has been suggested that local protein degradation in distal axons and dendrites is important for quality control of synaptic proteins, and also for plasticity and remodeling of synapses (13) (14) (15) (16) (17) (18) (19) (20) . However, in the absence of tools to selectively inhibit proteasomes at synapses the precise role of local proteasome activity remains unclear.
Proteasome activity is regulated at multiple levels, including transcription of proteasomal proteins, assembly of subunits, post-translational modifications, and the utilization of different regulatory particles (10, (21) (22) (23) . One structurally conserved proteasome regulator is PI31 ("proteasome inhibitor of 31kD"). PI31 was originally discovered based on its ability to inhibit hydrolysis of small peptides by 20S particles in vitro (24, 25) . Conversely, studies in Drosophila, yeast and plants indicate that PI31 promotes protein breakdown in vivo (26) (27) (28) .
PI31 can be ADP-ribosylated by Tankyrase, and this modification promotes assembly of 26S proteasome (29) . PI31 also binds directly to Fbxo7/PARK15, a conserved F-box protein that is the substrate-recognition component of an SCF E3-ligase complex (26, 30-32) . Unexpectedly, loss of Fbxo7 causes cleavage and inactivation of PI31, reduced proteasome activity and neuronal degeneration
Results

Generation of PI31-Null mice
In order to examine the physiological role of PI31, we used two independent approaches to generate constitutive and conditional PI31 loss-offunction mouse mutants (Fig. 1) . First, we used CRISPR/Cas9 technology to introduce a 16 bp deletion in exon 1 of the mouse PI31 gene. This resulted in a frame shift and a premature stop codon ( Fig. 1A, B , C). Western blot analysis confirmed that no PI31 protein was detectable in PI31 CRISP/CRISP embryos, indicating that this allele is a Null-mutant ( Fig. 1D ). PI31 CRISP/CRISP embryos appeared normal overall prior to embryonic stage E13.5. However, at E15.5 small size differences became detectable and by E18.5 reduced growth was apparent ( Fig. 1E ). Histological analysis of these embryos indicated that many tissues and organs, such as heart, kidney, gut, muscle and skin, developed normally overall and contained differentiated cells with appropriate morphology and patterning (Fig. S1 ). We conclude that PI31 function, unlike complete inactivation of proteasomes, is not universally required for the growth, differentiation and survival of many cell types.
Because PI31 complete knockout mutants died at advanced embryonic stages, we generated conditional PI31 mutants in order to more carefully examine the role of PI31 in post-embryonic cell types. For this purpose, we used the "knockout-first" (KOF) strategy which allows the production of reporter knockouts, conditional knockouts, and Null-alleles following exposure to the sitespecific recombinases Cre and Flp (59, 60) . A PI31 knockout-first (PI31 KOF ) mutant line was generated from commercially available ES cell (Psmf1 tm1a(EUCOMM)Hmgu ) as illustrated in Fig. 1F . The lacZ insertion introduces a strong splice acceptor, which is predicted to cause severe truncation of the PI31 protein and eliminate domains critical for function ( Fig. 1F ). Similar to PI31 CRISP/CRISP mice, PI31 KOF/KOF mice are recessive embryonic lethal, and by E15.5 embryos were hemorrhagic and smaller in size (Fig. 1G ). Western blot analysis confirmed that PI31 protein was not detectable in PI31 KOF/KOF embryos ( Fig. 1I ). We conclude that both the PI31 CRISP/CRISP and PI31 KOF/KOF strains represent loss-of-function mutants in which expression of PI31 protein was successfully ablated, and that PI31 is an essential gene for mouse development.
In order to generate conditional alleles for more in-depth analysis of PI31 function in specific post-embryonic cell types, PI31 KOF mice were bred with mice expressing FLP1 recombinase to generate a PI31 allele where the third exon is flanked by two loxP sites (PI31 fl , Psmf1 tm1c(EUCOMM)Hmgu )( Fig. 1H ). PI31 fl/fl mice express normal levels of PI31, are viable, fertile and appear completely normal.
However, introduction of various Cre-drivers successfully inactivated PI31 and led to tissue specific loss of PI31 protein, as indicated in Fig. 1J .
Inactivation of PI31 causes neurological defects, proteotoxic stress and reduced proteasome assembly
We used PI31 fl/fl mice to investigate the physiological role of PI31 in different types of neurons. First, we crossed PI31 fl/fl mice to CDX2-Cre mice to inactivate PI31 in the caudal part of the embryo. PI31 fl/fl /CDX2-Cre mice were viable but around P6 they began to develop progressive neuromotor phenotypes, characterized by spasticity, rigid muscle tone, strong tremor and a severely impaired righting response ( Fig. 2A , Movie S1). When these mice were picked up by their tail, they displayed hind leg clasping between episodes of tremor, a hallmark of neuromotor dysfunction (Fig 2A) . Mutant mice were only able to move using their front legs since their hind limbs were hyperextended and paralyzed ( Fig. 2A , Movie S1). These phenotypes became progressively more severe with age, and by 3-4 weeks all mice succumbed. We also noted that although PI31 was deleted in all caudal tissues -including skin, muscle and kidney -we did not find any significant phenotype in these tissues.
Next, we looked for evidence that protein homoestasis was disrupted in PI31 fl/fl /CDX2-Cre mice. For this purpose, we used the FK2 antibody to detect accumulation of poly-Ub proteins, which serves as a readout for proteasome function (61) . While no differences between control and PI31 fl/fl /CDX2-Cre were seen in protein extracted from muscle or kidney, we detected a clear and significant accumulation of poly-Ub proteins in spinal cord extracts from mutant mice (Fig. 2B ). Highest levels of FK2 staining were seen in P9 mutant mice, at a time when motoric problems were apparent, but well before the peak of this phenotype and death of mutant animals (Fig. 2C) . These observations indicate that inactivation of PI31 in the spinal cord leads to defects in the degradation of poly-Ub proteins, consistent with impaired proteasome function. It was previously shown that PI31 can promote the assembly of active 26S proteasomes from 19S and 20S particles (29) . Therefore, we investigated whether loss of PI31 affects the proteasome profile. For this purpose, we used Western blot analysis of native gels to analyze extracts from mouse embryonic fibroblasts (MEF) derived from PI31 KOF/KOF embryos and controls ( Fig. 2D, E ).
This revealed a small but significant reduction in the levels of single-capped 26S proteasomes, without substantial change of individual subunits (Fig. S2A ). It is worth noting that PI31-Null MEFs were viable for extended periods in culture, indicating that these biochemical changes and the modest accumulation of poly-Ub conjugates in mutant MEFs under normal growth conditions did not have profound biological consequences ( Fig. S2 ). We also saw induction of p62, which is a hallmark of proteotoxic stress ( Fig. S2B ), (62, 63) . Since p62 delivers poly-Ub aggregates to the autophagic machinery for degradation in lysosome, it is possible that this backup pathway can clear proteins escaping degradation in PI31-Null MEFs sufficiently well enough to avoid overt biological consequences.
We also treated MEFs with different concentrations of the proteasome inhibitors bortezomib and MG132 to look for a role of PI31 under conditions where protein breakdown is compromised (64). For both proteasome inhibitors, we observed that PI31-Null MEFs survived less well ( Fig. S2C, D ). This reveals a modest but significant requirement for PI31 function in fibroblasts under stress conditions. Taken together, our results indicate that loss of PI31 causes decreased proteasome activity and reduces the breakdown of poly-Ub proteins, but that this has little biological consequence for many cell types. In contrast, neurons appear to be particularly sensitive to the loss of PI31 function.
Inactivation of PI31 in motor neurons disrupts the neuro-muscular junction (NMJ) and models ALS phenotypes In order to examine a possible requirement of PI31 in neurons in more detail, we used several specific neuronal Cre-lines. To ablate PI31 function specifically in motor neurons we used Hb9-Cre (65, 66). PI31 fl/fl Hb9-Cre mice were initially viable but developed motor defects, kyphosis of the spine and muscle atrophy by the age of 5 months that became progressively more severe with age ( Fig. 3 A, B ). External inspection of these mice revealed severe kyphosis due to atrophy and weakness of paraspinal muscles, and also overt motoric defects that recapitulate phenotypes described for mouse ALS models ( Fig. 3A , Movie S2) (53, 54, 67) . Histological analysis of thoracic cross sections of 5-month old PI31 fl/fl Hb9 cre mice revealed highly atrophied musculature in PI31 mutants ( Fig. 3A ) and concomitant reduction in body weight ( Fig. 3B ). Next, we examined the architecture of the Neuro-Muscular Junction (NMJ) by staining motor neuron axons with β3-Tubullin/Synapsin, and the post-synaptic muscle end plate with α-Bungarotoxin ( Fig. 3C ). Compared to age-matched controls, PI31 mutants displayed severe structural abnormalities, including presynaptic fragmentation of the NMJ, axonal tip swellings, and massive axonal sprouting that are all notable at the age of 5 months (Fig. 3C ). These phenotypes recapitulate defects described for several other mouse ALS models (53, 67, 68) .
The swelling of axonal tips was apparent in PI31-Null motor neurons as early as 1 month after birth and became progressively more severe with age ( Fig. 3D ).
Interestingly, no overt morphological abnormalities were detectable in motor neuron cell bodies at this stage (data not shown). Moreover, conditional inactivation of PI31 in muscle did not cause any striking anatomical or behavioral phenotypes, even in mice that were aged up to 8 months. Finally, we also observed accumulation of p62-positive aggregates at the NMJ of PI31 fl/fl Hb9-Cre mice, but not in control littermates, indicating that loss of PI31 disrupts proteostasis in axon terminals of motor neurons (Fig. 3E ). Notably, these phenotypes are remarkably similar to those caused by conditional inactivation of Rpt3, a critical component of the proteasome regulatory particle (54, 69) . Rpt3, also termed PSMC4, is a critical component of the proteasome regulatory particle and required for the degradation of most proteasome substrates (69).
Inactivation of PI31 in Purkinje cells causes progressive motor defects and disrupts protein homeostasis
We also examined the role of PI31 in the cerebellum, as it provides an outstanding model for studying how proteotoxic stress impairs neuronal function, structure and survival (70) (71) (72) (73) (74) (75) (76) (77) (78) . Purkinje cells are very large neurons that are particularly sensitive to proteotoxic stress, which is thought to be a major factor contributing to cerebellar diseases (71, 79) . As the Purkinje cell is the sole output neuron of the cerebellar cortex, defects in Purkinje cell function cause both motor and cognitive dysfunction. We used the Purkinje cell-specific Cre driver Tg(Pcp2-Cre) to examine how conditional loss of PI31 affects the health, structure, and viability of these cells as well as associated mouse behaviors.
Behavioral analysis of PI31 fl/fl PCP2-cre mice revealed a series of defects characteristic for impaired Purkinje cell function, and these defects became progressively more severe with age. First, we used the ledge test and gait analysis to look for possible abnormalities in motor coordination in PI31 fl/fl Pcp2-Cre mice . At P22, PI31 fl/fl Pcp2-Cre mice were indistinguishable from their PI31 fl/fl littermates. However, by P30, PI31 fl/fl Pcp2-Cre mice displayed an aberrant halting gait and frequently lost their balance on the ledge test ( Fig. 4B ).
By P60, mutants had severely disrupted balance, frequently dragged their bodies along the ledge and fell on their heads when lowering themselves into the cage.
Locomotor defects were also seen with gait analysis in older mutant mice ( Fig.   4C ; Movie S3). Taken together, these behavioral abnormalities suggest defects in Purkinje cell function.
Next, we looked for evidence of changes in protein degradation and cellular structure of Purkinje cells. At P22, Purkinje cells did not appear to have morphological abnormalities in PI31 fl/fl PCP2-cre mice, with well-developed dendritic arbors and axonal morphology ( Fig. 4E, F) . However, we observed increased staining for Ub-GFP, a marker indicating proteotoxic stress, already at this stage ( Fig. 4F ). By P30, Purkinje cell primary and secondary dendrites appeared swollen in PI31 fl/fl PCP2-Cre mice (Fig. 4G) . Significantly, Purkinje cell axon terminals in the DCN had swellings with increased Ub-GFP, indicating impaired protein breakdown ( Fig. 4H ). We also found that loss of PI31 caused swellings along the length of the axons in the white matter. These swellings were positive for Ub-GFP, indicating impaired protein breakdown in mutant PC axons ( Fig. 4I ). Interestingly, it appeared that the compartment most affected by the loss of PI31 at this stage was the Purkinje cell axon. By P60, the DCN contained large aggregates throughout which were positive for both poly-Ub conjugates and p62 ( Fig. 5, Fig. S3 ). Quantification revealed a striking increase in p62-positive aggregates between 1 and 2-month old mutant mice (Fig. 5D ).
These data demonstrate that the loss of PI31 function exposes Purkinje cells to proteotoxic stress that progressively increases over time.
Many neurodegenerative diseases are associated with gliosis (glial cell reactivation and proliferation), which often precedes the formation of aggregates, tangles and plaques (71, 79) . An increase in glial fibrillary acid-protein (GFAP) and hypertrophy of astrocytes are markers of astrogliosis (80). In the mouse cerebellum, GFAP mainly stains the Bergmann glia in the Purkinje and molecular layers, and astrocytes which are predominantly found in the white matter. For PI31 fl/fl PCP2-cre mice, the GFAP staining at P22 was very similar to their control littermates ( Fig. S4 ). However, by P30, there was a dramatic increase in reactive astrocytes in the DCN, but not the Purkinje or molecular layers (Fig. S4 ). This indicates that the Purkinje cell axon terminals are damaged in such a way as to induce gliosis at this time. At P60, we observed some reactive astrocytes in the Purkinje layer, coinciding with the onset of Purkinje cell loss.
An extension of this analysis to older mice revealed that mutant Purkinje cells had lost almost all their axon terminals in the DCN by the age of 10 months ( Fig. 6A ). We also observed axonal torpedoes, focal swellings on Purkinje cell axons that have long been associated with cerebellar disorders (Fig. 6B ) (81-84).
In addition, at this time there was a major reduction in Purkinje cell number ( Fig.   6B , C). This striking loss of Purkinje cells upon inactivation of PI31 is consistent with the motor defects revealed by gait analysis in these mice. Collectively, our results indicate that loss of PI31 initially impairs local protein homeostasis in axons and dendrites of Purkinje cells and disrupts their structure, and that over time this compromises cell survival.
Discussion
In the present study, we addressed the physiological role of PI31 ("proteasome inhibitor of 31kD") in mammals by generating complete and conditional PI31 mouse mutants. In contrast to the function implied by its original name, we provide compelling evidence for a role of PI31 in stimulating protein breakdown that is critical for maintaining synaptic structures and long-term survival of neurons. Interestingly, the first morphological defects caused by conditional inactivation of PI31, in both motor neurons and Purkinje cells of the cerebellum, were observed in the distal part of neurons, namely axons and synapses. These structural defects were accompanied by molecular proteotoxic stress markers (Ub-GFP, FK2 and P62) at the NMJ and in deep cerebellar nuclei (DCN). Importantly, symptoms became progressively more severe with age, culminating in the degeneration of axons and dendrites, and eventually cell loss.
These morphological abnormalities were also associated with motoric problems, modeling ALS and cerebellar disorders, respectively. Overall, these observations suggest that PI31 activity is required for protein homeostasis in distal compartments of neurons.
A plausible mechanistic explanation for these defects comes from our recent finding that PI31 serves as an adapter protein to mediate fast axonal transport of proteasomes (43). PI31 can directly bind to dynein light chain proteins and thereby couples proteasomes to cellular motors. Significantly, inactivation of PI31 in Drosophila blocks proteasome motility and disrupts synaptic protein homeostasis and structure. This function of PI31 is conserved from insects to mammals, since inactivation of PI31 in mouse hippocampal neurons impairs proteasome movement in axons as well (43). Although we have not yet been able to perform live cell imaging analyses to directly demonstrate a requirement of PI31 for proteasome movement in mouse motor neurons or Purkinje cells, impaired transport of proteasomes in axons and dendrites provides an attractive explanation for the observed defects in protein homeostasis at nerve endings. Synapses are highly dynamic sites of active local protein synthesis, which has to be balanced by local protein degradation (85). According to our model, inactivation of PI31 leads to a shortage of proteasomes at synapses, which in turn causes the accumulation of poly-Ub proteins and p62positive aggregates. It appears that backup clearance mechanisms, such as autophagy and possibly also shedding of microvesicles/exosomes, can partially compensate for the loss of PI31-mediated proteasome activity in PI31 mutants (6, 43, (86) (87) (88) (89) (90) . The latter would also explain the gliosis that we observed already at P30 in PI31 fl/fl PCP2-Cre mice. However, even if backup clearance pathways are induced, neurons eventually succumb to defects in the absence of PI31 function.
Interestingly, conditional inactivation of PI31 in motor neurons resulted in kyphosis and ALS-like behavioral phenotypes comparable to inactivation of Rpt3, an essential component of the proteasome 19S regulatory particle (54). This is somewhat surprising, since Rpt3, unlike PI31, is an essential component of the proteasome regulatory particle. In the mouse embryo, complete inactivation of Rpt3 causes a much more severe phenotype (Rpt3-deficient mice die before implantation) than complete inactivation of PI31 (69). Unlike PI31, inactivation of Rpt3 primarily disrupted protein homeostasis in the motor neuron cell body (54).
We interpret this to indicate the importance of localized proteasome activity in axons and dendrites of neurons: whereas Rpt3 function is required in every cellular compartment, including the nucleus and cell body, PI31-mediated proteasome transport appears to be particularly important for protein homeostasis in axons and dendrites. Since neuronal activity critically relies on proper synaptic function, it may be particularly sensitive to perturbation of synaptic protein homeostasis mediated by PI31. Moreover, it is also possible that proteasomes can be active independent of the main regulatory particle, at least to a certain degree and in some subcellular compartments. Together, the critical and conserved role of PI31 in proteasome transport, the accumulation of non-degraded poly-Ub conjugates and induction of proteotoxic stress in PI31 mutants, and comparison with Rpt3 inactivation in motor neurons, all support a function of PI31 as a positive regulator of proteasome activity.
The activity of PI31 critically depends on Fbxo7, also termed PARK15 in humans, which encodes the substrate-recognition component of an SCF E3ligase complex and binds directly to PI31 (26, [30] [31] [32] . Conditional inactivation of PI31 in mice causes neuronal degeneration, and human mutations in Fbxo7/PARK15 are associated with neurodegenerative diseases (33, 34, 42, 91, 92) . Strikingly, inactivation of Fbxo7 leads to severe reduction of PI31 protein and reduced proteasome activity in both Drosophila and mice (26, 32, 33) . This suggests the possibility of a direct mechanistic link between PI31, reduced proteasome function and human disease. However, a role for PI31 in mediating the proteasome impairment and neuronal degeneration observed in Fbxo7/PARK15 mutants was dismissed based on results from cell culture experiments (33, 93) . The current study, together with the work of Liu et al.
(2019), suggest that this topic deserves more careful examination (43). MEFs deficient for PI31 survived for extended periods of time, and we were unable to detect a major reduction of total proteasome activity in these cells. However, local defects in proteasome activity would not have been revealed by these approaches. When combined with proteasome inhibitors, inactivation of PI31 resulted in a small but significant reduction of cell survival. These findings are consistent with the reported role of the yeast PI31 ortholog to alleviate proteotoxic stress (27) . We also saw that PI31-Null MEFs had slight defects in proteasome assembly, as indicated by reduced numbers of single-capped 26S particles. Therefore, PI31 may regulate proteasomes by multiple mechanisms: through the assembly of functional 26S proteasomes from 19S and 20S particles, and via transport (29, 43) . In any event, it appears that neurons are particularly sensitive to the loss of PI31 function, and a neuro-protective role of PI31 should not be ruled out based on results with non-neuronal immortalized cells.
A neuro-protective role of PI31 was particularly obvious in motor neurons and Purkinje cells, two major types of neurons with long axons. Therefore, it is possible that large neurons axons are especially sensitive to the impairment of PI31-mediated proteasome transport since they face a particularly challenging problem in allocating proteasomes to compartments where protein breakdown has to occur. Moreover, Purkinje cells are very sensitive to proteotoxic stress, and Purkinje cell pathology is a common finding in cerebellar diseases (47, 71, 79) . Consistent with this, inactivation of PI31 in these cells caused proteotoxic stress as soon as these cells matured (P22), and it led to behavioral and anatomical defects that are characteristic for cerebellar diseases. These include progressively more severe loss of balance and defects in gait, which coincided with axonal swelling, torpedoes, gliosis and eventually loss of Purkinje cell bodies.
It is well known that protein clearance mechanisms decline during the aging process, and impairment of the UPS in neurodegenerative diseases has been widely reported (35, 36, 39, 40, 90, (94) (95) (96) (97) . Most of the attention in previous studies has been focused on the ability of aggregates to inhibit proteasome activity (37, 41). However, aggregate-mediated proteasome inhibition cannot explain the failure to degrade poly-Ub proteins and accumulate aggregates in the first place. We suggest that impaired activity of PI31, caused either by mutations affecting PI31 function (such as Fbxo7/PARK15), or through epigenetic mechanisms during the normal aging process, contributes to agerelated neuronal degeneration. The mouse mutant strains described here provide powerful models to further investigate this possibility.
Materials and Methods
Mice
In order to generate PI31 mutant using CRISPR\Cas9 technology we have designed a single-guide targeting RNA that will target the mouse PSMF1 gene in the first exon right after the first Methionine (Psmf1a-1 CACCGAACGGCTACTATGCCTT, Psmf1a-2 AAACAAGGCATAGTAGCCGTTC). Targeting sequence was ordered as oligos and cloned into plasmid px330 (A gift from Dr. Zhang lab) that contains both Cas9 and the tracer RNA sequence. ES cell were transfected with this plasmid and Surveyor assay was performed to assess targeting efficiency. Gene targeting resulted in 5 mutant lines, all of which were heterozygous for an indel in the PSMF1 gene. After sequencing the relevant genomic loci we have decided to continue our research with one clone, which have a 16bp deletion in the first exon (nt103-118 of ORF) that results in a frame shift and a premature stop codon in the second exon (nt239). Homozygous mutants are not viable and die perinatal; hence, we used tissue from E13 homozygous mutant embryos (which are morphologically similar to wild types) to test the presence of PI31 protein.
For the generation of conditional PI31 knockout mice, we have purchased commercially available ES cell (Psmf1 tm1a(EUCOMM)Hmgu ). We sequenced these ES cells to validate they harbor PI31 knockout first allele with conditional potential. 
Chimeras were generated by injection of targeted ES cells into albino blastocysts
Behavioral Tests
Ledge test: The mouse was placed on the ledge of the cage and scored for coordination and balance (98). A mouse which walked the ledge with few slips and descended into the cage gracefully, landing on its paws, was given a score of 0. A mouse which lost its footing received a score of 1. A mouse that did not use its hind paws well and landed on its head instead of its paws when descending into the cage received a score of 2. A mouse that refused to move, even with gentle encouragement, or fell or nearly fell while walking the ledge or lowering itself into the cage received a score of 3.
Gait Analysis: The fore paws of each mice were painted with nontoxic red paint and the hind paws were painted with nontoxic blue paint, after which the mice were allowed to walk on paper along a 10 cm wide by 76 cm long corridor with 20 cm high opaque walls. This was done three times for each mouse and each parameter was measured for the three longest strides in the middle of a run. The footprint patterns were analyzed for three step parameters (all measured in centimeters). As per Carter et al., four parameters were measured: (1) Stride length was measured as the average distance of forward movement between each stride. (2) Hind-base width, or sway, was measured as the average distance between left and right hind footprints. These values were determined by measuring the perpendicular distance of a given step to a line connecting its opposite preceding and proceeding steps. (3) Distance from left hind footprint to right hind was measured to determine stance length (99).
Native gel electrophoresis
Protein extracts of tissue were prepared in buffer (50 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 0.5 mM EDTA, 2 mM ATP, 0.2% NP4, protease inhibitor, phosphatase inhibitor (Pfizer), using liquid nitrogen freezing and thawing technique. Extracts were cleared by centrifugation at 14, 000 RPM for 30 min to remove nuclei and cell debris, and protein concentrations were measured by Bradford assay. To resolve proteasomes, 26-well 3-8% Tri-acetate gels (Criterion) were used. Samples were mixed with 2X native loading buffer (Bio-Rad) just before loading. Electrophoresis were carried out at RT (1 hour at 50V) and then at 4°C for additional 5 hours at 120V, in running buffer (0.45M Tris, 0.45M Boric Acid, 5mM EDTA, 12.5 mM MgCl2, supplied with 0.5 mM DTT, 0.5 mM ATP). For immunoblotting, proteins in native gels were transferred to 0.45 mm PVDF membranes. 26S and 20S were detected with anti-Alpha7 antibodies (1:5000, Enzo). Purified bovine 20S, and 26S proteasomes (UBPBio), were used as standards.
Antibodies and Western blot
Protein extracts were prepared as for Native gel electrophoresis. For western blotting, proteins were resolved by SDS-PAGE and transferred onto a 0.45 mm PVDF membrane. Membranes were blocked overnight at 4°C with 5% milk in phosphate buffered saline (PBS) and 0.5% Tween-20 (PBST). Membranes were incubated for 60 min with one of the following antibodies: FK2 (Enzo ,1:2000), PI31 (Thermo Fisher,1:2000), Actin HRP conjugated (Cell Signaling,1:10000), Tubulin. Primary antibodies were detected by secondary species-specific HRPcongugated antibodies (Jackson ImmunoResearch, 1:5000). Detection was performed with Amersham ECL Western Blotting Detection Reagent (GE Healthcare).
Cell Survival Assay
Low cycle (4-6) primary mouse embryonic fibroblasts from wild type or PI31 KO embryos were seeded in a 96 well plate at a concentration of 15,000 cells per well and incubated over night in DMEM containing 10% FBS and penicillin/streptomycin at 37°C under 5% CO2 (v/v). Then, cells were incubated for additional 18-22 hours with different concentration of the proteasome inhibitors Bortezomib or MG132, three wells per concentration. Cell viability was measured using PrestoBlue viability reagent (molecular probed, life technologies) as described in the manufacture protocol. Experiment was repeated three independent times.
Immunofluorescence Muscle innervation
Whole mount staining of triangularis sterni muscle was done as described in Brill et al., Neuron 2016 (100). Briefly, the thoracic wall containing the triangularis sterni muscle was dissected and fixed in 4% PFA for 1 hour on ice. The fixed tissue was then washed for 10 minuets in 0.1M glycine and the triangularis sterni muscle dissected out. The dissected muscle was transferred into blocking solution (10% goat serum, 0.5% TX-100 in PBS) for 1 hour at room temperature. Quantification of axonal swellings -for the quantification of axonal swellings, zstack images of age matched PI31 f/f controls and PI31 f/f Hb9:Cre KO animals were taken at low magnification (10x). Maximal intensity Z-projects images were generated using Fiji software and axonal swellings were counted manually.
Average number of axonal swelling was calculated based on 3 images per animal. Image size -850 m 2 . 1MO -control n= 3, KO n=3, 3MO -control n=2, KO n=3, 5MO -control n=2, KO n=4. P-Value was calculated using the student ttest.
Immunofluorescence of cerebellar sections
Mice were perfused with 4% PFA/PBS, the brains were removed and then postfixed in 4% PFA/PBS overnight. They were then washed in PBS, soaked in 15% sucrose/PBS for several hours until they sank, and then soaked in 30% sucrose/PBS overnight. The brains were then embedded in Richard-Allan Scientific Neg-50™ Frozen Section Medium (Thermo Scientific) and 50 µm sagittal sections were made using a Leica CM 3050S cryostat.
Primary antibodies used for immunofluorescence included rabbit anti-GFP 
Figure Legends
Fig. 1: Inactivation of PI31 results in embryonic lethality
Two independent approaches were used to generate constitutive and conditional PI31 loss-of-function mouse mutants.
A. CRISPR/Cas9 technology was used to introduce a 16 bp deletion in exon 1 of the were measured in multiple tissues 2 weeks after tamoxifen injection. 
